Fiat 500X

Bitget to list HOLD Token: Empowering Futures Trading with Holdstation

Retrieved on: 
Monday, December 25, 2023

Bitget to list HOLD Token: Empowering Futures Trading with Holdstation

Key Points: 
  • Bitget to list HOLD Token: Empowering Futures Trading with Holdstation
    The issuer is solely responsible for the content of this announcement.
  • Bitget, a leading cryptocurrency exchange and Web3 company, proudly announces the listing of HOLD , the governance token of Holdstation, on its innovative trading platform.
  • Holdstation is revolutionizing the landscape of Smart Contract Wallets for Futures Trading by leveraging the power of zkSync Era technology.
  • Holdstation stands out as an innovative Smart Contract Wallet for Futures Trading, offering users a seamless experience on the zkSync Era.

Brenig Therapeutics Unveils Superior Safety Profile of LRRK2 Inhibitor BT-0267 with Exceptional CSF/Plasma Ratio at Future of Parkinson's Disease Conference

Retrieved on: 
Monday, December 4, 2023

The results were unveiled at the prestigious Future of Parkinson's Disease Conference.

Key Points: 
  • The results were unveiled at the prestigious Future of Parkinson's Disease Conference.
  • LRRK2, recognized as a crucial drug target in Parkinson's disease, plays a major role in the pathogenesis of the condition.
  • Inhibiting LRRK2 activity has emerged as a promising disease-modifying therapeutic strategy, and several drug candidates have achieved clinical status.
  • The BT-0267 candidate has an efficient blood-brain barrier penetration while minimized peripheral exposure as well as has a superior overall safety profile.

Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics

Retrieved on: 
Tuesday, October 10, 2023

SAN FRANCISCO, Oct. 10, 2023 /PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are showcasing their work next week at the National Society of Genetic Counselors (NSGC) 42nd Annual Conference in Chicago that highlights the importance of genetics-informed patient care. In addition to its research presentations, the company will present the Heart of Genetic Counseling Award which recognizes excellence in the field of genetic counseling.

Key Points: 
  • In addition to its research presentations, the company will present the Heart of Genetic Counseling Award which recognizes excellence in the field of genetic counseling.
  • "The NSGC Annual Conference is a great opportunity for Invitae researchers to share cutting-edge scientific advancements with genetic counselors who play an integral role in genetics-informed patient care," said Robert Nussbaum, M.D., chief medical officer at Invitae.
  • Invitae joins NSGC in presenting the Heart of Genetic Counseling Award – honoring excellence in genetic counseling and patient care as recognized by patients.
  • To learn more about Invitae's presence at the NSGC 42nd Annual Conference or the Heart of Genetic Counseling Award, visit our website .

Passport Bros Introduces the Game-Changing Airdrop of $BROS Token.

Retrieved on: 
Monday, September 25, 2023

London, UK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- With the new developments, Passport Bros introduces the game-changing airdrop of the $BROS token.

Key Points: 
  • London, UK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- With the new developments, Passport Bros introduces the game-changing airdrop of the $BROS token.
  • The $BROS Token Airdrop program marks a significant leap forward in decentralized finance (DeFi), offering a lucrative opportunity for crypto enthusiasts and newcomers to enter the crypto space.
  • In a rapidly evolving digital world, $BROS Token aims to redefine the way we think about decentralized finance (DeFi), social connections, and financial empowerment.
  • You earn 3 $BROS tokens at Level 1 and an additional 2 $BROS tokens at Level 2, making it not only lucrative but also engaging.

SKYVIEW 1 Launches Digital Banking Platform for Financial Advisors to Provide Clients With End-to-end Service and Competitive Rates, Building More Momentum for Their Money

Retrieved on: 
Thursday, July 27, 2023

SKYVIEW 1 partners with RIAs and broker-dealers to provide a bespoke digital banking service for consumers, including a cutting-edge mobile experience.

Key Points: 
  • SKYVIEW 1 partners with RIAs and broker-dealers to provide a bespoke digital banking service for consumers, including a cutting-edge mobile experience.
  • This new banking as a service (BaaS) platform enables advisors to provide end-to-end service and advice, grounded in a foundational understanding of their clients’ complete financial picture, that can steer high-net-worth investors toward greater financial momentum.
  • SKYVIEW 1 presents an unparalleled opportunity for advisors to grow their assets under management (AUM) and augment their client service.
  • “Financial advisors are constantly in search of new ways to add value for their clients,” said Aaron Dillon , co-founder of SKYVIEW 1.

NVIDIA Announces DGX GH200 AI Supercomputer

Retrieved on: 
Monday, May 29, 2023

TAIPEI, Taiwan, May 28, 2023 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced a new class of large-memory AI supercomputer — an NVIDIA DGX ™ supercomputer powered by NVIDIA ® GH200 Grace Hopper Superchips and the NVIDIA NVLink® Switch System — created to enable the development of giant, next-generation models for generative AI language applications, recommender systems and data analytics workloads.

Key Points: 
  • TAIPEI, Taiwan, May 28, 2023 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced a new class of large-memory AI supercomputer — an NVIDIA DGX ™ supercomputer powered by NVIDIA ® GH200 Grace Hopper Superchips and the NVIDIA NVLink® Switch System — created to enable the development of giant, next-generation models for generative AI language applications, recommender systems and data analytics workloads.
  • DGX GH200 is the first supercomputer to pair Grace Hopper Superchips with the NVIDIA NVLink Switch System, a new interconnect that enables all GPUs in a DGX GH200 system to work together as one.
  • DGX GH200 supercomputers include NVIDIA software to provide a turnkey, full-stack solution for the largest AI and data analytics workloads.
  • Also included is NVIDIA AI Enterprise , the software layer of the NVIDIA AI platform.

Iconic FIAT Brand Launches in Algeria

Retrieved on: 
Sunday, March 19, 2023

Stellantis announces launch of six FIAT carlines coming to Algerian customers starting March 21: Fiat 500 Hybrid, Fiat 500X, Fiat Tipo, Fiat Doblò, Fiat Scudo and Fiat Ducato

Key Points: 
  • Stellantis announces launch of six FIAT carlines coming to Algerian customers starting March 21: Fiat 500 Hybrid, Fiat 500X, Fiat Tipo, Fiat Doblò, Fiat Scudo and Fiat Ducato
    ALGIERS, ALGERIA, March 19, 2023 – Stellantis today announces the launch of FIAT brand in Algeria to meet the Algerian customers’ expectations with a wide range of models during a ceremony chaired by Mr. Ali Aoun, Minister of Industry and Pharmaceutical Production, Mr. Tayeb Zitouni, Minister of Commerce and Export, HE.
  • “Supporting the Fiat project and hence, the development of the automotive ecosystem in Algeria has an historical symbolism that reflects the long-lasting good relations between the two countries.
  • “This morning we celebrate the return to Algeria of Fiat: an iconic brand with one of the five longest automotive traditions in the world.
  • So, in Algeria, there’s already a FIAT for every need” said Olivier François, FIAT brand CEO.

Light & Wonder Showcases Pioneering New WONDER 500™ Product Exclusively with Sky Betting & Gaming

Retrieved on: 
Monday, February 6, 2023

Light & Wonder, Inc. (NASDAQ: LNW) (“Light & Wonder,” “L&W”) presents its new, ground-breaking Wonder 500™ product exclusively with Sky Betting & Gaming in the UK.

Key Points: 
  • Light & Wonder, Inc. (NASDAQ: LNW) (“Light & Wonder,” “L&W”) presents its new, ground-breaking Wonder 500™ product exclusively with Sky Betting & Gaming in the UK.
  • This innovative product which combines proven mechanics and themes, offers a new take on casino entertainment, which players can enjoy safely and responsibly.
  • Light & Wonder’s long-term operator partner Sky Betting & Gaming will exclusively roll out the first Wonder 500™ games to their players later this month, with MIGHTY BLACK KNIGHT™, SPARTACUS™ and ROD & ANNETTE GO FISHING™ amongst the first titles from the series to hit the market.
  • “Wonder 500™ is a fantastic addition to Light & Wonder’s in-house portfolio of games and we can’t wait to put the product in front of our audience.

Fiat 500X Offers Enticing Entry Point on Cars.com Affordability Report: 2023 Best Value New Cars

Retrieved on: 
Monday, January 23, 2023

Fiat 500X features high price-to-value equation with technology, roomy interior and standard all-wheel drive (AWD)

Key Points: 
  • Fiat 500X features high price-to-value equation with technology, roomy interior and standard all-wheel drive (AWD)
    Loaded with up to 75 advanced safety and security features, the Fiat 500X is available in Pop and Sport trims
    2023 Fiat 500X has a starting U.S. manufacturer's suggested retail price (MSRP) of $28,965 (excluding $1,595 destination charge)
    Cars.com is giving the Fiat 500X affordability kudos on its Affordability Report: 2023 Best Value New Cars.
  • The 2023 Fiat 500X in Pop trim has a starting U.S. manufacturer's suggested retail price (MSRP) of $28,965, excluding $1,595 destination charge.
  • The 2023 Fiat 500X delivers Italian design and engaging driving dynamics that are synonymous with the FIAT brand.
  • Loaded with up to 75 advanced safety and security features, the 2023 Fiat 500X is available in two trims: Pop and Sport.

CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)

Retrieved on: 
Thursday, December 8, 2022

HOUSTON, Dec. 8, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced preliminary results from its ongoing potentially pivotal trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM).

Key Points: 
  • "Berubicin continues to demonstrate its ability to be an innovative treatment in GBM as a safe and potentially effective therapy.
  • These preliminary findings bolster our conviction in Berubicin as we continue to advance this study forward.
  • Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer.
  • CNS Pharmaceuticals is evaluating the use of the WP1244 portfolio in the treatment of brain cancers, pancreatic, ovarian, and lymphomas.